A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers

Journal of Immunology

Volumn 162, Issue 3, 1999, Pages 1827-1835

  Tan, Linda C ^a   Gudgeon, Nancy ^b   Annels, Nicola E ^b   Hansasuta, Pokrath ^a   O'Callaghan, Chris A ^a   Rowland Jones, Sarah ^a   McMichael, Andrew J ^a   Rickinson, Alan B ^b   Callan, Margaret F C ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HERPES VIRUS; HUMAN; HUMAN CELL; LATENT VIRUS INFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS CARRIER; VIRUS LATENCY;

ADULT; AMINO ACID SEQUENCE; ANTIGENS, VIRAL; CARRIER STATE; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HLA ANTIGENS; HUMANS; PHENOTYPE; TIME FACTORS; VIRAL PROTEINS;

EID: 0033082487     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus. In Virology, 3rd Ed. B. N. Fields, D. M. Knipe, P. M. Howley, eds. Lippincott-Raven, Philadelphia, p. 2397.
2. Sixbey, J. W., J. G. Nedrud, N. Raab-Traub, R. A. Hanes, and J. S. Pagano. 1984. Epstein-Barr virus replication in oropharyngeal cells. N. Engl. J. Med. 310:1225.
3. Tierney, R. J., N. Steven, L. S. Young, and A. B. Rickinson. 1994. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68:7374.
4. Murray, R. J., M. G. Kurilla, J. M. Brooks, W. A. Thomas, M. Rowe, E. Kieff, and A. B. Rickinson. 1992. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J. Exp Med. 176:157.
5. Khanna, R., S. R. Burrows, M. G. Kurilla, C. A. Jacob, I. S. Misko, T. B. Sculley, E. Kieff, and D. J. Moss. 1992. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vacinia: implications for vaccine development. J. Exp. Med 176:169.
6. Steven, N. M., A. M. Leese, N. E. Annels, S. P. Lee, and A. B. Rickinson. 1996. Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory. J. Exp. Med. 184:1801.
7. Borysiewicz, L. K., J. K. Hickling, S. Graham, J. Sinclair, M. P. Cranage, G. L. Smith, and J. G. P. Sissons. 1988. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J. Exp. Med. 168:919.
8. + herpes simplex virus-specific cytotoxic T lymphocyte clones recognise diverse virion protein antigens. J. Virol. 66:1622.
9. Bogedain, C., H. Wolf, S. Modrow, G. Stuber, and W. Jilg. 1995. Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. J. Virol. 69:4872.
10. Steven, N. M., N. E. Annels, A. Kumar, A. M. Leese, M. G. Kurilla, and A. B. Rickinson. 1997. Immediate early and early lyric cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J. Exp. Med. 185:1605.
11. + T cells during the primary immune response to Epstein Barr virus in vivo. J. Exp. Med. 187:1395.
12. Scotet, E., J. David-Ameline, M.-A. Peyrat, A. Moreau-Aubry, D. Pinczon, A. Lim, J. Even, G. Semana, J.-M. Berthelot, R. Breathnach, et al. 1996. T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J. Exp. Med 184:1791.
13. Elliott, S. L., S. J. Pye, C. Schmidt, S. M. Cross, S. L. Silins, and I. S. Misko. 1997. Dominant cytotoxic T lymphocyte response to the immediate early transactivator protein BZLF1, in persistent type A or B Epstein Barr virus infection. J. Infect. Dis. 176:1068.
14. + T cells: a re-evaluation of bystander activation during viral infection. Immunity 8:177.
15. + memory T cells. J. Exp. Med 186:859.
16. Altman, J. D., P. A. H. Moss, P. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen specific T lymphocytes. Science 274:94.
17. + T cells during an acute virus infection. Immunity 8:167.
18. McMichael, A. J., and C. A. O'Callaghan. 1998. A new look at T cells. J. Exp. Med 187:1367.
19. Krausa, P., D. Barouch, J. G. Bodmer, and M. J. Browning. 1995. Rapid characterisation of HLA class I alleles by gene mapping using ARMS PCR. Eur. J. Immunogenet. 22:283.
20. Burrows, S. R., T. B. Sculley, I. S. Misko, C. Schmidt, and D. J. Moss. 1990. An Epstein-Barr virus-specific cytotoxic T cells epitope in EBNA3. J. Exp. Med. 171:345.
21. Burrows, S. R., J. Gardner, R. Khanna, T. Steward, D. J. Moss, S. Rodda, and A. Suhrbier. 1994. Five new cytotoxic T-cell epitopes identified within Epstein-Barr virus nuclear antigen 3. J. Gen. Virol. 75:2489.
22. Hill, A. B., A. Worth, T. Elliott, S. Rowland-Jones, J. M. Brooks, A. B. Rickinson, and A. J. McMichael. 1995. Characterisation of two Epstein-Barr virus epitopes restricted by HLA-B7. Eur. J. Immunol 25:18.
23. Gavioli, R., M. G. Kurilla, P. O. de Campos Lima, L. E. Wallace, R. Dolcetti, R. J. Murray, A. B. Rickinson, and M. G. Masucci. 1993. Multiple HLA-A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenecities in the Epstein-Barr virus-encoded nuclear antigen 4. J. Virol. 67:1572.
24. Waldmann, T. A. 1991. The interleukin-2 receptor. J Biol. Chem. 266:2681.
25. Hara, T., S. M. Fu, and J. A. Hansen. 1985. Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen). J. Exp. Med. 161:1513.
26. Spertini, O., F. W. Luscinskas, G. S. Kansas, J. M. Munro, J. D. Griffin, M. A. Gimbrone, Jr., and T. F. Tedder. 1991. Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J. Immunol. 147:2565.
27. Akbar, A. N., L. Terry, A. Tirams, P. C. L. Beverley, and G. Janossy. 1988. Loss of CD45R and gain of UCHL 1 reactivity is a feature of primed T cells. J. Immunol. 140:2171.
28. + T lymphocytes are derived from CD57 precursors by differentiation occurring in late immune responses. Eur. J. Immunol. 24:1503.
29. Lefkovits, L., and H. Waldmann. 1979. Limiting Dilution Analysis of Cells in the Immune System. Cambridge University Press, Cambridge and New York.
30. Moss, P. A., S. L. Rowland-Jones, P. M. Frodsham, S. McAdam, P. Giangrande, A. J. McMichael, and J. I. Bell. 1995. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc. Natl Acad. Sci. USA 92:5773.
31. - T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J. Exp. Med. 180:489.
32. Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104.
33. + T cells. J. Exp. Med. 186:1407.
34. 3H]R I-superinfected Raji cells. J. Virol. 61:3120.
35. Kieff, E., and D. Liebowitz. 1990 Epstein-Barr virus and its replication. In Virology. 2nd Edn. B. N. Fields and D. M. Knipe, eds. Raven Press, New York, p. 1889.
36. Lieberman, P. M., P. O'Hare, G. S. Hayward, and S. D. Hayward. 1986. Promiscuous trans activation of gene expression by an Epstein-Barr virus-encoded early nuclear protein. J. Virol. 60:140.
37. Falk, K. I., J. Z. Zou, E Lucht, A. Linde, and I. Ernberg. 1997. Direct identification by PCR of EBV types and variants in clinical samples. J. Med Virol. 51:355.
38. Rowe, M., A. L. Lear, D. Croom-Carter, A. H. Davies, and A. B. Rickinson. 1992. Three pathways of Epstein-Barr virus gene activation from EBNA-1-positive latency in B lymphocytes. J. Virol. 66:122.
39. Prang, N. S., M. W. Hornef, M. Jager, H. J. Wagner, H. Wolf, and F. M. Schwarzmann. 1997. Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state. Blood 89:1665.
40. Sutkowski, N., T. Palkama, C. Ciurli, R.-P. Sekaly, D. A. Thorley-Lawson, and B. T. Huber. 1996. An Epstein-Barr virus-associated superantigen. J. Exp. Med. 184:971.
41. Hsu, D. H., R. de Waal Malefyt, D. F. Fiorentino, M. N. Dang, P. Vierira, J. de Vries, H. Spits, T. R. Mosmann, and K. W. Moore. 1990. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250:830.
42. + population. Science 260:98.
43. Ho, M., R. Jaffe, G. Miller, M. K. Breinig, J. S. Dummer, L. Makowka, R. W. Archison, F. Karrer, M. A. Nalesnik, and T. E. Starzl. 1988. The frequency of Epstein-Barr virus infection and associated lymphoproliferative disease after transplantation and its manifestations in children. Transplantation 45:719.
44. Rooney, C. M., C. A. Smith, C. Y. C. Ng, S. Loftin, C. Li, R. A. Krance, M. K. Brenner, and H. E. Heslop. 1995. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus related lymphoproliferation. Lancet 345:9.
45. Papadopoulos, E., M. Ladanyi, D. Emmanuel, S. Mackinnon, F. Boulad, M. H. Carabasi, H. Castro-Malaspina, B. H. Childs, A. P. Gillio, T. N. Small, et al. 1994. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med 330:1185.
46. Cochet, C. D. Martel-Renoir, V. Grunewald, J. Bosq, G. Cochet, G. Schwaab, J.-F. Bernaudin, and I. Joab. 1993. Expression of the Epstein-Barr virus immediate early gene. BZLF1 in nasopharyngeal carcinoma tumour cells. Virology 197:358.
47. Brooks, L., Q. Y. Yao, A. B. Rickinson, and L. S. Young. 1992. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMPI, and LMP2 transcripts. J. Virol. 66:2689.
48. Deacon, E. M., G. Pallesen, G. Niedobitek, J. Crocker, L. Brooks, A. B. Rickinson, and L. S. Young. 1993. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J. Exp. Med. 177:339.
49. Kielf, E. 1996. Epstein-Barr virus and its replication. In Virology, 3rd Edn. B. N. Fields, D. M. Knipe, and P. M. Howley, eds. Lippincott-Raven, Philadelphia, p. 2343.
50. Burrows, S. R., R. Khanna, J. M. Burrows, and D. J. Moss. 1994. An alloresponse in humans in dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein Barr virus CTL epitope: implications for graft versus host disease. J. Exp. Med 179:1155.